Ionic Pharmaceuticals
Pre-clinicalTraditional nanoparticle based drug delivery systems suffer from poor accumulation in tumors. At Ionic Pharmaceuticals, our patented nanoparticle employs a unique Materials-Based Targeting strategy to achieve a 50X improvement in delivery efficiency. We demonstrate an increase in survival of over 200%.
Founded
2019
Focus
Drug DeliveryNanotechnology
About
Traditional nanoparticle based drug delivery systems suffer from poor accumulation in tumors. At Ionic Pharmaceuticals, our patented nanoparticle employs a unique Materials-Based Targeting strategy to achieve a 50X improvement in delivery efficiency. We demonstrate an increase in survival of over 200%.
Funding History
1Total raised: $15M
Series A$15MUndisclosedMar 15, 2021
Company Info
TypePrivate
Founded2019
LocationCambridge, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile